1 |
Tussing L, Chapman-Novakofski K. Osteoporosis prevention education: behavior theories and calcium intake. J Am Diet Assoc. 2005. 105: 92-97.
DOI
ScienceOn
|
2 |
Williams MJ, Poulton R, Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 2002. 165: 179-184.
DOI
ScienceOn
|
3 |
Yousefladeh G, Larijani B, Mohammadirad A, Heshrnat R, Dehghan G, Rahimi R, Abdollahi M. Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects. Ann N Y Acad Sci. 2006. 1091: 142-150.
DOI
ScienceOn
|
4 |
Cheng S, Suominen H, Sakari-Rantala R, Laukkanen P, Avikainen V, Heikkinen E. Calcaneal bone mineral density predicts fracture occurrence: a five-year follow-up study in elderly people. Journal of Bone and Mineral Research. 1997. 12: 1075-1082.
DOI
ScienceOn
|
5 |
Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses. 1991. 35: 96-102.
DOI
ScienceOn
|
6 |
Ryan P, Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr Med Res Opin. 2006. 22: 211-216.
DOI
ScienceOn
|
7 |
World Health Organization. Prevention and Management of Osteoporosis. Report of a WHO Scientific Group WHO Technical Report Series, No 921. 2003.
|
8 |
Shin CS, Choi HJ, Kim MJ, Kim JT, Yu SH, Koo BK, Cho HY, Cho SW, Kim SW, Park YJ, Jang HC, Kim SY, Cho NH. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density. Bone 2010. 47: 378-387.
DOI
ScienceOn
|
9 |
Yamasaki K, Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicology Letters 2009. 191: 211-215.
DOI
|
10 |
Wasnich RD, Ross PD, Heilbrun LL, Vogel JM. Selection of the optimal skeletal site for fracture risk prediction. Clinical Orthopaedics and Related Research 1987. 216: 262-269.
|
11 |
Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen YT, Sherwood LM, Abbott TA. Predictive value of low BMD for I-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: results from the National Osteoporosis Risk Assessment (NORA). Journal of Bone and Mineral Research 2004. 19: 1215-1220.
DOI
ScienceOn
|
12 |
Cummings SR, Blaek DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM. Bone density at various sites for prediction of hip fractures. The Lancet 1993. 341: 72-75.
DOI
ScienceOn
|
13 |
Ramakrishnan U, Kuklina E, Stein AD. Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr. 2002. 76: 256-260.
|
14 |
Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992. 86: 803-811.
DOI
ScienceOn
|
15 |
Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Pipemo A, Fiorelli G. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol. 1997. 24: 1809-1813.
|
16 |
Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley DA, Ioannidis G, Josse RG, Kovacs CS, Towheed T, Kaiser S, Olszynski WP, Prior JC, Jamal S, Kreiger N, Goltzman D. Canadian Multicentre Osteoporosis Study (CaMos) Research Group. Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int. 2010. Oct 22.
|
17 |
Altindag O, Erel O, Soran N, Celik H, Selek S. Total oxidative/ anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int. 2008. 28: 317-321.
DOI
ScienceOn
|
18 |
Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int. 2009. 20: 549-555.
DOI
ScienceOn
|
19 |
Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987. 7: 137-142.
DOI
|
20 |
Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988. 29: 378-384.
DOI
ScienceOn
|
21 |
Olsson R, Johansson C, Lindstedt G, Mellstrom D. Risk factor for bone loss in chronic active hepatitis and primary biliary cirrhosis. Scand J Gastroenterol. 1994.29: 743-756.
|
22 |
Gardsell P, Johnell O, Nilsson BE, Gullberg B. Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcified Tissue International 1993. 52: 348-353.
DOI
ScienceOn
|
23 |
Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res. 1991. 6: 39-43.
|
24 |
Diamond T, Stiel D, Lunzre M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1999. 31: 82-87.
|
25 |
Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007. 50: 949-956.
DOI
ScienceOn
|
26 |
Isaia G, D'Amelio P, Di Bella S, Tamone C. Protein intake: the impact on calcium and bone homeostasis. J Endocrinol Invest. 2007.30: 48-53.
|
27 |
Lalor BC, France MW, Powel D, Adams PH, Counichan TB. Bone and mineral metabolism and chronic alcohol abuse. QJ Med. 1986. 59: 497-511.
|